Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ipsen (IPN.FP)

Ipsen (IPN.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Ipsen 70 rue Balard Paris 75015 FRA

P: +33 158335000

Sector:

N/A

INDUSTRY GROUPING:

N/A

Description:

Ipsen is a global biotechnology company headquartered in France that develops and commercializes medicines across three therapeutic areas: oncology, neuroscience, and rare diseases. Ipsen was founded in 1929 as a consumer healthcare company focused on prescription-based products for digestive disorders and neurological disorders. Over the past nearly 100 years, Ipsen has shifted its focus to specialty care, which comprises the vast majority of its total revenue. In February 2022, Ipsen announced the divestment of its consumer healthcare business, which accounted for 8% of 2021 revenue. Ipsen has a large global footprint and sells more than 25 drugs in 115 countries.

Key Statistics

Overview:

Market Capitalization, $K 13,604,653
Shares Outstanding, K 82,387
% of Institutional Shareholders 17.38%

Financials:

Annual Sales, $ 3,575 M
Annual Net Income, $ 345,900 K

Growth:

1-Year Return 50.23%
3-Year Return 50.23%
5-Year Return 135.86%
5-Year Revenue Growth 5.83%
5-Year Dividend Growth 3.71%

Per-Share Information:

Next Earnings Date N/A
Earnings Per Share ttm 5.37
EPS Growth vs. Prev Year -0.46%
Annual Dividend & Yield (Paid) 1.40 (0.85%)
Annual Dividend & Yield (Fwd) 1.40 (0.85%)
Most Recent Dividend 1.400 on 06/04/25
Next Ex-Dividends Date 06/04/25
Dividend Payable Date 06/06/25
Dividend Payout Ratio 26.07%

IPN.FP Ratios

Ratio
Price/Earnings ttm 30.74
Price/Earnings forward 17.51
Price/Earnings to Growth 0.91
Return-on-Equity % 10.82%
Return-on-Assets % 6.70%
Profit Margin % 9.68%
Debt/Equity 0.09
Price/Sales 3.66
Price/Cash Flow 14.11
Price/Book 3.22
Book Value/Share 51.32
Interest Coverage 11.33
60-Month Beta N/A
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar